Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–46 of 46 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03866382	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	recruiting	Phase 2	314	National Cancer Institute (NCI)NIH	2	Sep 29, 2026	clinicaltrials
NCT06406465	A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity	recruiting	Phase 2	60	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials